Nitric oxide mediates intestinal pathology in graft‐vs.‐host disease
- 1 August 1992
- journal article
- research article
- Published by Wiley in European Journal of Immunology
- Vol. 22 (8) , 2141-2145
- https://doi.org/10.1002/eji.1830220827
Abstract
We have investigated the involvement of nitric oxide (NO) in intestinal graft‐vs.‐host reaction (GvHR) in mice. Treatment of mice with L‐NG‐monomethyl arginine (L‐NMMA), a specific inhibitor of NO synthesis, abolished the mucosal pathology of intestinal GvHR and reduced the associated lymphocytic infiltration of the epithelium. L‐NMMA had no effect on splenomegaly in GvHR, nor did it interfere with the growth of an undifferentiated crypt stem cell line, or the production of tumor necrosis factor‐α by activated macrophages in vitro. In contrast, L‐NMMA inhibited the enhanced activity of natural killer (NK) cells which occurs in GvHR. We conclude that a NO‐dependent mechanism is essential for intestinal immunopathology in GvHR and that this may reflect a role for NO in NK cell function.Keywords
This publication has 12 references indexed in Scilit:
- Role of nitric oxide synthesis in macrophage antimicrobial activityPublished by Elsevier ,2003
- Potentiation of tumor necrosis factor-alpha-mediated cytotoxicity of mast cells by their production of nitric oxide.The Journal of Immunology, 1991
- Widespread tissue distribution, species distribution and changes in activity of Ca2+‐dependent and Ca2+‐independent nitric oxide synthasesFEBS Letters, 1991
- Inhibition of nitric oxide generation affects the induction of diabetes by streptozocin in miceBiochemical and Biophysical Research Communications, 1991
- Activated macrophages kill pancreatic syngeneic islet cells via arginine-dependent nitric oxide generationBiochemical and Biophysical Research Communications, 1991
- Activated macrophages destroy intracellular Leishmania major amastigotes by an L-arginine-dependent killing mechanism.The Journal of Immunology, 1990
- Specific assays for cytokine production by T cellsJournal of Immunological Methods, 1989
- Tumor necrosis factor/cachectin is an effector of skin and gut lesions of the acute phase of graft-vs.-host disease.The Journal of Experimental Medicine, 1987
- Intraepithelial Lymphocyte Count and Crypt Hyperplasia Measure the Mucosal Component of the Graft-versus-Host Reaction in Mouse Small IntestineGastroenterology, 1982
- Small Intestinal Injury in the Graft Versus Host Reaction: An Innocent Bystander PhenomenonGastroenterology, 1977